Literature DB >> 11409871

Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families.

S L Zheng1, J Xu, S D Isaacs, K Wiley, B Chang, E R Bleecker, P C Walsh, J M Trent, D A Meyers, W B Isaacs.   

Abstract

Prostate cancer is the most common malignancy diagnosed in men in the US. Genetic susceptibility to prostate cancer has been well documented. A region at chromosome 20q13 (HPC20) has been reported to be linked to a prostate cancer susceptibility gene. To confirm this finding, we genotyped 16 markers spanning approximately 95 cM on chromosome 20 in 159 hereditary prostate cancer (HPC) families. Positive (but not statistically significant) linkage scores were observed from 20pter to 20q11, with the highest non-parametric linkage (NPL) score for the complete dataset of 1.02 (P=0.15) being observed at D20S195 at 20q11. Evidence for linkage from parametric analyses with a dominant or a recessive model was weak. Interestingly, consistent with the original findings of linkage to 20 g higher linkage scores were observed in the subsets of families with a later age at diagnosis (> or =65 years; n=80, NPL=1.94, P=0.029 at D20S186), fewer than five affected family members (n=69, NPL=1.74, P=0.037 at D20S889), or without male-to-male disease transmission (n=60, NPL=1.01, P=0.15 at D20S117). The region with positive linkage scores spanned approximately 60 cM from 20pter to 20q11 in these subsets of families. Our results are consistent with a prostate cancer susceptibility locus on chromosome 20.

Entities:  

Mesh:

Year:  2001        PMID: 11409871     DOI: 10.1007/s004390100513

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

1.  Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.

Authors:  Danielle M Friedrichsen; Janet L Stanford; Sarah D Isaacs; Marta Janer; Bao-Li Chang; Kerry Deutsch; Elizabeth Gillanders; Suzanne Kolb; Katherine E Wiley; Michael D Badzioch; S Lilly Zheng; Patrick C Walsh; Gail P Jarvik; Leroy Hood; Jeffrey M Trent; William B Isaacs; Elaine A Ostrander; Jianfeng Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

2.  Clinical Correlates of Autosomal Chromosomal Abnormalities in an Electronic Medical Record-Linked Genome-Wide Association Study: A Case Series.

Authors:  Hayan Jouni; Khader Shameer; Yan W Asmann; Ribhi Hazin; Mariza de Andrade; Iftikhar J Kullo
Journal:  J Investig Med       Date:  2013-10       Impact factor: 2.895

3.  Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas.

Authors:  Jin Zhang; Seong-Jun Cho; Limin Shu; Wensheng Yan; Teri Guerrero; Michael Kent; Katherine Skorupski; Hongwu Chen; Xinbin Chen
Journal:  Genes Dev       Date:  2011-07-15       Impact factor: 11.361

4.  Polymorphisms in 9q32 and TSCOT are linked to cervical cancer in affected sib-pairs with high mean age at diagnosis.

Authors:  Malin T Engelmark; Emma L Ivansson; Jessica J Magnusson; Inger M Gustavsson; Per-Ivan Wyöni; Max Ingman; Patrik K E Magnusson; Ulf B Gyllensten
Journal:  Hum Genet       Date:  2008-04-08       Impact factor: 4.132

5.  Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.

Authors:  Phillippa J Neville; David V Conti; Pamela L Paris; Howard Levin; William J Catalona; Brian K Suarez; John S Witte; Graham Casey
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

Review 6.  Molecular basis for prostate cancer racial disparities.

Authors:  Santosh K Singh; James W Lillard; Rajesh Singh
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

Review 7.  The genetic epidemiology of prostate cancer and its clinical implications.

Authors:  Rosalind Eeles; Chee Goh; Elena Castro; Elizabeth Bancroft; Michelle Guy; Ali Amin Al Olama; Douglas Easton; Zsofia Kote-Jarai
Journal:  Nat Rev Urol       Date:  2013-12-03       Impact factor: 14.432

8.  The role of caveolin-1 and endothelial nitric oxide synthase polymorphisms in susceptibility to prostate cancer.

Authors:  Mahdieh Aliyari; Daniel Elieh Ali Komi; Amir Kiani; Mahmoudreza Moradi; Maryam Tanhapour; Zohreh Rahimi; Hadi Mozafari; Ehsan Mohammadi-Noori; Tayebeh Pourmotabbed; Asad Vaisi-Raygani; Fariborz Bahrehmand
Journal:  Int J Exp Pathol       Date:  2021-05-08       Impact factor: 1.925

9.  Clinical Correlates of Autosomal Chromosomal Abnormalities in an Electronic Medical Record-Linked Genome-Wide Association Study: A Case Series.

Authors:  Hayan Jouni; Khader Shameer; Yan W Asmann; Ribhi Hazin; Mariza de Andrade; Iftikhar J Kullo
Journal:  J Investig Med High Impact Case Rep       Date:  2013-10-18

10.  Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.

Authors:  Joan E Bailey-Wilson; Erica J Childs; Cheryl D Cropp; Daniel J Schaid; Jianfeng Xu; Nicola J Camp; Lisa A Cannon-Albright; James M Farnham; Asha George; Isaac Powell; John D Carpten; Graham G Giles; John L Hopper; Gianluca Severi; Dallas R English; William D Foulkes; Lovise Mæhle; Pål Møller; Rosalind Eeles; Douglas Easton; Michelle Guy; Steve Edwards; Michael D Badzioch; Alice S Whittemore; Ingrid Oakley-Girvan; Chih-Lin Hsieh; Latchezar Dimitrov; Janet L Stanford; Danielle M Karyadi; Kerry Deutsch; Laura McIntosh; Elaine A Ostrander; Kathleen E Wiley; Sarah D Isaacs; Patrick C Walsh; Stephen N Thibodeau; Shannon K McDonnell; Scott Hebbring; Ethan M Lange; Kathleen A Cooney; Teuvo L J Tammela; Johanna Schleutker; Christiane Maier; Sylvia Bochum; Josef Hoegel; Henrik Grönberg; Fredrik Wiklund; Monica Emanuelsson; Geraldine Cancel-Tassin; Antoine Valeri; Olivier Cussenot; William B Isaacs
Journal:  BMC Med Genet       Date:  2012-06-19       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.